3-Fluoro-5-methylphenyl methyl sulfide | 1314902-71-0

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 3-Fluoro-5-methylphenyl methyl sulfide
• 英文别名: 1-fluoro-3-methyl-5-methylsulfanylbenzene
• CAS: 1314902-71-0
• 化学式: C₈H₉FS
• mdl: MFCD11617787
• 分子量: 156.22
• InChiKey: BVQAOSZBXPPOFS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• [EN] IMIDAZO[1,2-B]PYRIDAZINES AS TRK INHIBITORS<br/>[FR] IMIDAZO[1,2-B]PYRIDAZINES UTILISÉES EN TANT QU'INHIBITEURS DE TRK
  申请人：BENEVOLENTAI BIO LTD

  公开号：WO2020039209A1

  公开（公告）日：2020-02-27

  The present invention relates to certain imidazo[1,2-b]pyridazine compounds and the pharmaceutically acceptable salts of such compounds. The invention also relates to the processes for the preparation of the compounds, compositions containing the compounds, and the uses of such compounds and salts in treating diseases or conditions associated with tropomyosin-related kinase (Trk), activity. More specifically the invention relates to the compounds and their salts useful as inhibitors of Trk. Formula (I) wherein R1, R2, R3, R4 and R5, L and Z are as defined herein.

  本发明涉及某些咪唑并[1,2-b]吡啶嗪化合物以及这些化合物的药用盐。本发明还涉及制备这些化合物的过程、含有这些化合物的组合物、以及这些化合物和盐在治疗与肌浆蛋白相关激酶（Trk）活性相关的疾病或症状中的用途。更具体地，本发明涉及作为Trk抑制剂有用的化合物及其盐。公式（I）中R1、R2、R3、R4和R5、L和Z的定义如本文所述。
• [EN] TOPICAL PHARMACEUTICAL COMPOSITIONS COMPRISING IMIDAZO[1,2-B]PYRIDAZINE COMPOUNDS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES TOPIQUES COMPRENANT DES COMPOSÉS IMIDAZO[1,2-B]PYRIDAZINE
  申请人：BENEVOLENTAI BIO LTD

  公开号：WO2021148805A1

  公开（公告）日：2021-07-29

  The present invention relates to pharmaceutical compositions, such as topical pharmaceutical compositions, comprising certain imidazo[1,2-b]pyridazine compounds and the pharmaceutically acceptable salts and/or solvates of such compounds. The invention also relates to the processes for the preparation of the pharmaceutical compositions, and the uses of such compositions in treating diseases or conditions associated with tropomyosin-related kinase (Trk) activity. More specifically the invention relates to topical pharmaceutical compositions comprising a compound of Formula (I) or a pharmaceutically acceptable salts and/or solvates thereof, which are useful in inhibiting Trk.

  本发明涉及药物组合物，例如局部药物组合物，包括某些咪唑[1,2-b]吡啶嗪化合物及该类化合物的药用可接受的盐和/或溶剂化合物。该发明还涉及制备药物组合物的方法，以及利用这些组合物治疗与肌浆蛋白相关激酶（Trk）活性相关的疾病或症状。更具体地，该发明涉及包含化合物（I）的局部药物组合物或其药用可接受的盐和/或溶剂化合物，这些组合物在抑制Trk方面是有用的。
• 3, 5-DISUBSTITUTED PHENYL-PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION
  申请人：NSAB, Filial af NeuroSearch Sweden AB, Sverige

  公开号：EP1948606B1

  公开（公告）日：2011-01-05
• HERBIZID WIRKSAME 3-PHENYLISOXAZOLINDERIVATE
  申请人：Bayer CropScience AG

  公开号：EP2900645A1

  公开（公告）日：2015-08-05